Pds Biotechnology Share Price Today
(NASDAQ: PDSB)

Name: Pds Biotechnology Share Price (NASDAQ: PDSB) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Pds Biotechnology share price is $1.22 & ₹104.31 as on 9 May 2025, 2.30 'hrs' IST

$1.22

▲

0.06

(5.17%)

Market is closed - opens 7 PM, 09 May 2025

View live Pds Biotechnology share price in Dollar and Rupees. Guide to invest in Pds Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pds Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Pds Biotechnology share price movements

Today's Low: $1.18
Today's High: $1.25
$1.22
3.28%
Downside
Day's Volatility :5.6%
Upside
2.4%
52 Weeks Low: $0.85
52 Weeks High: $4.42
$1.22
30.29%
Downside
52 Weeks Volatility :80.76%
Upside
72.4%

Pds Biotechnology (PDSB) Returns

Period	Pds Biotechnology Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-16.44%	-7.6%	0.0%
6 Months	-62.92%	-9.9%	0.0%
1 Year	-68.15%	-5.6%	0.0%
3 Years	-72.71%	7.0%	0.4%

Pds Biotechnology (PDSB) Key Statistics

in dollars & INR

Previous Close	$1.16
Open	$1.18
Today's High	$1.25
Today's Low	$1.18
Market Capitalization	$62.6M
Today's Volume	$132.0K
52 Week High	$4.42
52 Week Low	$0.8505
Revenue TTM	$0.0
EBITDA	$-36.3M
Earnings Per Share (EPS)	$-1.03
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-166.65%

How to invest in Pds Biotechnology Stock (PDSB) from India?

It is very easy for Indian residents to invest directly in Pds Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pds Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pds Biotechnology or PDSB on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pds Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pds Biotechnology shares which would translate to 0.701 fractional shares of Pds Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pds Biotechnology, in just a few clicks!

Returns in Pds Biotechnology (PDSB) for Indian investors in Rupees

The Pds Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Pds Biotechnology investment value today

Current value as on today

₹34,257

Returns

₹65,743

(-65.74%)

Returns from Pds Biotechnology Stock

₹68,146 (-68.15%)

Dollar Returns

₹2,404 (+2.4%)

Indian investors sentiment towards Pds Biotechnology (PDSB)

-45%

Period: Apr 8, 2025 to May 8, 2025. Change in 30 Days versus previous period

Search interest for Pds Biotechnology Stock from India on INDmoney has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pds Biotechnology

Vanguard Group Inc
3.38%
BlackRock Inc
1.17%
Geode Capital Management, LLC
0.94%
Susquehanna International Group, LLP
0.55%
Citadel Advisors Llc
0.49%
Blair William & Co
0.35%

Analyst Recommendation on Pds Biotechnology

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Pds Biotechnology(by analysts ranked 0 to 5 stars)

Analyst Forecast on Pds Biotechnology Stock (PDSB)

What analysts predicted

Upside of 514.75%

Target:

$7.50

Current:

$1.22

Insights on Pds Biotechnology Stock (Ticker Symbol: PDSB)

Price Movement
In the last 7 days, PDSB stock has moved down by -15.2%
PDSB vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 82.8% return, outperforming this stock by 152.3%
PDSB vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 125.8% return, outperforming this stock by 200.5%

Pds Biotechnology Technicals Summary

Sell

Neutral

Buy

Pds Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Pds Biotechnology (PDSB) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pds Biotechnology Corp	17.0%	-62.92%	-68.15%	-72.71%	29.24%
Regeneron Pharmaceuticals, Inc.	-5.1%	-33.93%	-43.46%	-11.02%	-4.67%
Beone Medicines Ltd	12.71%	14.87%	39.96%	64.27%	44.57%
Vertex Pharmaceuticals Incorporated	-10.78%	-16.72%	2.7%	79.18%	50.84%
Alnylam Pharmaceuticals, Inc.	6.4%	-6.7%	71.0%	101.94%	81.73%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pds Biotechnology Corp	NA	NA	NA	-0.98	-1.67	-0.43	NA	0.5
Regeneron Pharmaceuticals, Inc.	15.39	15.39	1.3	35.79	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.06	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.37	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.07	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pds Biotechnology Corp	Buy	$62.6M	29.24%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$65.4B	-4.67%	15.39	31.94%
Beone Medicines Ltd	NA	$29.5B	44.57%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.8B	50.84%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.6B	81.73%	NA	-11.49%

About Pds Biotechnology

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T cell receptor gamma alternate reading framed protein for treating acute myeloid leukemia, prostate, and breast cancer; and PDS0103 for ovarian, breast, colorectal, and lung cancers. In addition, the company is developing PDS01ADC, a novel investigational Interleukin 12 fused antibody-drug conjugate, tumor-targeting interleukin 12 immune-cytokine that enhances the proliferation, potency, and longevity of T cells in the tumor microenvironment. Further, the company provides PDS0202, a novel investigational influenza vaccine that protects against the strains predicted to be prevalent in an upcoming flu season. It has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Princeton, New Jersey.

Organization	Pds Biotechnology
Employees	24
CEO	Dr. Frank K. Bedu-Addo Ph.D.
Industry	Biotechnology

Management People of Pds Biotechnology

Name	Title
Dr. Frank K. Bedu-Addo Ph.D.	President, CEO & Director
Mr. Stephan Toutain M.B.A., M.S.	Chief Operating Officer
Dr. Kirk V. Shepard M.D.	Chief Medical Officer
Mr. Lars Robert Boesgaard M.B.A.	Principal Financial & Accounting Officer and CFO
Dr. Gregory L. Conn Ph.D.	Chief Scientific Officer
Mr. Spencer Brown J.D.	Senior VP, General Counsel, Corporate Secretary & Chief Compliance Officer
Ms. Janetta Trochimiuk	Controller

Important FAQs about investing in PDSB Stock from India :

What is Pds Biotechnology share price today?

Pds Biotechnology share price today stands at $1.22, Open: $1.18 ; Previous Close: $1.16 ; High: $1.25 ; Low: $1.18 ; 52 Week High: $4.42 ; 52 Week Low: $0.85.

The stock opens at $1.18, after a previous close of $1.16. The stock reached a daily high of $1.25 and a low of $1.18, with a 52-week high of $4.42 and a 52-week low of $0.85.

Can Indians buy Pds Biotechnology shares?

Yes, Indians can invest in the Pds Biotechnology (PDSB) from India.

With INDmoney, you can buy Pds Biotechnology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pds Biotechnology at zero transaction cost.

How can I buy Pds Biotechnology shares from India?

It is very easy to buy Pds Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pds Biotechnology (PDSB) be purchased?

Yes, you can buy fractional shares of Pds Biotechnology with INDmoney app.

What are the documents required to start investing in Pds Biotechnology stocks?

To start investing in Pds Biotechnology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.